Comparative therapeutic results of penicillin plus chloramphenicol versus ampicillin plus sulbactam in childhood meningococcemia.
Fifty-seven cases of meningococcemia were evaluated retrospectively. The age of the patients ranged between 2 and 17 years. Of the 57 patients investigated for the efficacy of antibiotic treatment, 31 (54.4%) were treated with benzylpenicillin plus chloramphenicol and 26 (45.6%) with ampicillin plus sulbactam. Patients with criteria for a poor prognosis (presence of disseminated intravascular coagulation, low arterial blood pressure, and altered consciousness) were divided equally into two treatment groups. There were no statistically significant differences between the two treatment groups except for the higher incidence of convulsion in the group given penicillin plus chloramphenicol. The mortality rate was 19.3 percent for patients treated with benzylpenicillin plus chloramphenicol and 7.6 percent for patients treated with ampicillin plus sulbactam (p = 0.19; overall mortality rate 14%).
Kanra
G
G
Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Seçmeer
G
G
Ozen
H
H
Ceyhan
M
M
Ecevit
Z
Z
D000293:Adolescent; D000667:Ampicillin / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D010406:Penicillins / Q000008:administration & dosage*; D011379:Prognosis; D012189:Retrospective Studies; D013407:Sulbactam / Q000008:administration & dosage*
D010406:Penicillins; D002701:Chloramphenicol; D000667:Ampicillin; D013407:Sulbactam